|
1
|
Silva JA, Mesquita Kde C, Igreja AC, Lucas
IC, Freitas AF, Oliveira SM, Costa IM and Campbell IT:
Paraneoplastic cutaneous manifestations: Concepts and updates. An
Bras Dermatol. 88:9–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sterz G: Polymyositis. Berliner Klinische
Wochenschrift. 53:4891916.
|
|
3
|
Zhang X, Wang Y, Ma G, Zhang L, Jing H and
Du J: Dermatomyositis as a symptom of primary lung cancer: A case
report and review of the literature. Oncol Lett. 11:3413–3416.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Souza FH and Shinjo SK: Newly diagnosed
dermatomyositis in the elderly as predictor of malignancy. Rev Bras
Reumatol. 52:713–721. 2012.(In English, Portuguese).
|
|
5
|
Zahr ZA and Baer AN: Malignancy in
myositis. Curr Rheumatol Rep. 13:208–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miret M, Horváth-Puhó E, Déruaz-Luyet A,
Sørensen HT and Ehrenstein V: Potential paraneoplastic syndromes
and selected autoimmune conditions in patients with non-small cell
lung cancer and small cell lung cancer: A population-based cohort
study. PLoS One. 12:e01815642017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Porto L, Miranda M, Gomes A, André R and
Rodrigues B: Paraneoplastic neurological syndrome as an initial
indicator of small cell carcinoma of the lung. BMJ Case Rep.
2013:bcr20120084322013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Santacroce L: Paraneoplastic syndromes.
Drugs & Diseases. 2017, https://emedicine.medscape.com/article/280744-overviewUpdated
December 06 2018.
|
|
9
|
Kanaji N, Watanabe N, Kita N, Bandoh S,
Tadokoro A, Ishii T, Dobashi H and Matsunaga T: Paraneoplastic
syndromes associated with lung cancer. World J Clin Oncol.
5:197–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sparsa A, Liozon E, Herrmann F, Ly K,
Lebrun V, Soria P, Loustaud-Ratti V, Bouyssou-Gauthier ML,
Boulinguez S, Bédane C, et al: Routine vs extensive malignancy
search for adult dermatomyositis and polymyositis: A study of 40
patients. Arch Dermatol. 138:885–890. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Basset-Seguin N, Roujeau JC, Gherardi R,
Guillaume JC, Revuz J and Touraine R: Prognostic factors and
predictive signs of malignancy in adult dermatomyositis. A study of
32 cases. Arch Dermatol. 126:633–637. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pelosof LC and Gerber DE: Paraneoplastic
syndromes: An approach to diagnosis and treatment. Mayo Clin Proc.
85:838–854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iorizzo LJ III and Jorizzo JL: The
treatment and prognosis of dermatomyositis: An updated review. J Am
Acad Dermatol. 59:99–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kovacs SO and Kovacs SC: Dermatomyositis.
J Am Acad Dermatol. 39:899–920. 1998. View Article : Google Scholar : PubMed/NCBI
|
